Patents
Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
07/2009
07/30/2009US20090192202 4-(2-Cyano-cyclohexyloxy)-2-trifluoromethyl-benzonitrlle; selective androgen receptor modulators; decrease excess sebum secretions; stimulants of hair growth at higher rates of cosmetically acceptable hair growth in patients with alopecia; acne; skin disorders; prostate cancer
07/29/2009EP2083005A1 Carbamic acid compounds comprising an amide linkage as HDAC inhibitors
07/29/2009EP1363876B1 Glucocorticoid receptor modulators
07/29/2009EP1326596B1 Pharmaceutical preparations containing a dibenzocyclooctane lignan derivative for prevention and treatment of neurodegenerative disease
07/29/2009CN100519547C Method for producing glycerol carbonate methacrylate
07/29/2009CN100519527C Inhibitors of histone deacetylase
07/23/2009WO2009089640A1 Derivatives of diacetyl as flavouring agents
07/23/2009US20090187032 INDUSTRIAL PROCESS FOR THE SYNTHESIS OF 17alpha-ACETOXY-11beta-[4-(N,N-DIMETHYL-AMINO)-PHENYL]-19-NORPREGNA-4,9-DIENE-3,20-DIONE AND NEW INTERMEDIATES OF THE PROCESS
07/23/2009CA2651010A1 Process for the preparation of stiripentol in defined granule size
07/22/2009EP1542981B1 Process for the preparation of 2-amino-4,5,6,7-tetrahydro-6-aminobenzothiazoles from cyclohexanes and cyclohexanones as intermediates
07/22/2009CN101490031A Novel process for preparing intermediates of CCR antagonists
07/22/2009CN100516034C Inhibitors of aspartyl protease
07/21/2009US7563792 Biguanide and dihydrotriazine derivatives
07/16/2009WO2009089210A1 Preparation of sulfamide derivatives
07/16/2009WO2009087395A1 Weight reducing compounds
07/16/2009US20090182157 New Process 054
07/16/2009CA2711466A1 Process for the preparation of sulfamide derivatives
07/15/2009CN100513403C Method for preparing cyclic carbonate by using catalysis of periodic usable functional polyglycol
07/14/2009US7560582 Use of specific bidentate ligands, e.g., 2-dicyclohexylphosphino-2'-dimethylamino-biphenyl, in transition metal-catalyzed carbon-heteroatom and carbon-carbon bond-forming reactions including amination and arylation and with aryl halide reactants and amine, boronic acid, borane or ketone reactants
07/14/2009US7560460 2-[(4-Chlorophenyl)methyl]-1-(4- {2-[(cyclopropylmethyl)-(methylsulfonyl)amino]phenyl }-piperazinyl) -4-(2-(1,2,3,4-tetrahydroisoquinolyl))butane-1,4-dione; obesity/dietietics; melanocortin receptor angonists; prophylaxis/treatment of diseases involving activation of the melanocortin recepetors (MCR)
07/09/2009WO2009085033A1 Alkylester fatty acid blends and uses therefor
07/09/2009WO2009083451A1 Addition reaction to fluoroallylfluorosulfate
07/09/2009US20090176997 Process for producing vinylene carbonate
07/09/2009US20090176993 (N-{5-[(4-chlorophenyl)thio]pentyl}-N-[(1R)-1-(1-naphthyl)ethyl]amine); mimics/blocks effect of extracellular calcium in parathyroid cells, juxtaglomerular/proximal tubule kidney cells, parafollicular thyroid cells, bone osteoclasts, keratinocytes or placental trophoblasts; hyperparathyroidism
07/09/2009US20090176786 Benzoylurea Compounds and Use Thereof
07/09/2009CA2710767A1 Alkylester fatty acid blends and uses therefor
07/08/2009EP2076505A1 Method for the synthesis of cyclic acetals by the reactive extraction of a polyol in a concentrated solution
07/08/2009CN101479252A Methods for the preparation of pyrazole-containing compounds
07/08/2009CN101475526A Carboxylic acid derivatives inhibiting the binding of integrins to receptors thereof
07/08/2009CN100509759C Novel alpha-oxygenated or alpha-thiolated carboxylic acid penethylamide derivatives
07/07/2009US7557140 e.g. 3-[3-(2,4-Difluoro-phenylsulfamoyl)-phenyl]-N-hydroxy-acrylamide; histone deacetylase inhibitor; anticarcinogenic, antiinflammatory agent, autoimmune diseases; leukemia, atheriosclerosis, Alzheimer's disease, rheumatoid arthritis, psoriasis
07/02/2009WO2009080446A1 2-methylthioethyl-substituted heyrrocycles as feed additives
07/02/2009WO2009079907A1 A method for preparing 4-[9-(6-aminopurine)]-2-(s)-hydroxyl-butyric acid methyl ester
07/02/2009US20090170881 New inhibitors of histone deacetylase
07/02/2009US20090170836 New inhibitors of histone deacetylase
07/02/2009US20090170824 Diarylsulfones as 5-HT2A Antagonists
07/02/2009CA2710170A1 2-methylthioethyl-substituted heterocycles as feed additives
07/01/2009EP2074109A1 Method of production of enantiomer-enriched alkylene carbonates
07/01/2009CN101471436A Cathode and manufacturing method thereof, secondary cell and manufacturing method thereof, and sulfone compound
07/01/2009CN100506814C Method of synthesizing landiolol hydrochloride
06/2009
06/30/2009US7553989 Such as monoacetyloxymethyl malonate; for use in production of prodrug-type carbapenem antibacterial agents for oral administration; cost efficiency
06/30/2009CA2406088C Novel phenyl-propargylether derivatives
06/25/2009WO2009077385A1 Leukotriene b4 inhibitors
06/25/2009US20090163576 Compounds for the treatment of metabolic disorders
06/25/2009US20090163496 Antibacterial agents
06/25/2009US20090163457 Compositions and methods for delivering a biologically active agent
06/25/2009US20090163404 Novel Dioxaspiro Compounds and Their Use in Perfume Compositions
06/25/2009US20090162474 2-methylthioethyl-substituted heterocycles as feed additives
06/25/2009DE102007062199A1 2-Methylthioethyl-substituierte Heterocyclen als Futtermitteladditive 2-methylthioethyl-substituted heterocycles as feed additives
06/25/2009CA2707990A1 Leukotriene b4 inhibitors
06/24/2009EP2072493A1 Organoleptic compounds
06/24/2009CN100503611C New use of specific cyclolignans
06/24/2009CN100503599C Carbonylamino-derivatives as novel inhibitors of histone deacetylase
06/23/2009US7550485 Conditions ameliorated by monoamine reuptake such as hot flashes, sexual dysfunction, gastrointestinal and genitourinary disorders, chronic fatigue syndrome, fibromylagia syndrome, nervous system disorders; e.g. 1-[2-(1,4'-bipiperidin-1'-yl)-1-(3-chlorophenyl)ethyl]cyclohexanol dihydrochloride
06/23/2009US7550456 substituted aryl cycloalkanoyl derivatives, compositions containing these derivatives, and methods of their use for the prevention and treatment of conditions ameliorated by monoamine reuptake including, inter alia, vasomotor symptoms (VMS), sexual dysfunction, gastrointestinal and genitourinary disorder
06/18/2009WO2009075823A1 Intermediates in the synthesis of zearalenone macrolide analogs
06/18/2009WO2009075818A1 Intermediates and methods for making zearalenone macrolide analogs
06/18/2009US20090156839 chemical intermediates; 2-chloromethyl-5,5-dimethyl-2-(2,5-dimethylphenyl)-[1,3]dioxane
06/18/2009CA2708143A1 Intermediates in the synthesis of zearalenone macrolide analogs
06/18/2009CA2708141A1 Intermediates and methods for making zearalenone macrolide analogs
06/17/2009EP2070915A1 New process for the synthesis of moguisteine
06/17/2009EP2069286A1 Inhibitors for glyt-1
06/17/2009EP2069274A1 Process for the preparation of alkylene glycol
06/17/2009EP1611088B1 Hydroxamates as therapeutic agents
06/17/2009CN100500679C Compound for adjusting functional activity of vascular endothelial cell, its preparation method as well as usage
06/16/2009US7547716 Sulfonamide derivatives
06/11/2009WO2009072502A1 Method for producing carbonate compound
06/11/2009WO2009072501A1 Method for producing carbonate compound
06/11/2009WO2009071651A1 Process for the preparation of alkylene glycol
06/11/2009WO2009071528A2 New process for the synthesis of moguisteine
06/11/2009WO2009070873A1 Substituted 2-naphthoic acids as antagonists of gpr105 activity
06/11/2009WO2008110278A3 Use of n2-phenylamidines as herbicides and herbicidal agents comprising the same
06/11/2009US20090149444 Benzylamine analogues
06/11/2009CA2707455A1 Process for the preparation of alkylene glycol
06/11/2009CA2706632A1 Substituted 2-naphthoic acids as antagonists of gpr105 activity
06/10/2009EP2066652A1 Process for the preparation of alkylene carbonate
06/10/2009EP1474385B1 Urea linker derivatives for use as ppar modulators
06/10/2009CN101450934A Sulfonyl-derivatives as novel inhibitors of histone deacetylase
06/10/2009CN100497326C Derivatives of 1-piperazine- and 1-homopiperazine-carboxylates, preparation method thereof and use of same in therapeutics
06/09/2009US7544835 Carboxylic acid derivative and salt thereof
06/09/2009US7544829 Photogenerated reagents
06/09/2009US7544717 2-amino- and 2-thio- substituted 1,3-diaminopropanes
06/09/2009US7544682 cancer; Methyl 5-((7-(((tert-butylamino)carbonyl)amino)-6-(2,6-dichlorophenyl)pyrido[2,3-d] pyrimidin-2-yl)amino)-1,3-benzodioxole-2-carboxylate; treating cellular proliferation disorders
06/09/2009US7544216 Unsubstituted and polymeric lactone colorants for coloring consumer products
06/09/2009CA2251331C Calcilytic compounds
06/04/2009US20090143592 Glucagon Antagonists/Inverse Agonists
06/03/2009EP2064177A2 Protease inhibitors
06/03/2009CN101445486A Derivatives of aryl-quinazoline/aryl-2-amino-phenyl methanone which promote the release of parathyroid hormone
06/03/2009CN100494327C Method for producing an oxygen-containing compound used as fuel additive, in particular in diesel fuels, gasoline and rapeseed methyl ester
06/02/2009US7541465 Substituted 2-aminoacetamides and the use thereof
06/02/2009US7541369 Amino-derivatives as novel inhibitors of histone deacetylase
05/2009
05/28/2009WO2009066072A2 Inhibitors of 17beta-hydroxysteroid dehydrogenase
05/28/2009US20090137826 Method for preparing 4beta-amino-4'-demethyl-4-desoxypodophyllotoxin
05/28/2009US20090137660 Cytokine Modulators Using Cyclic Glycerides of Essential Polyunsaturated Fatty Acids
05/28/2009US20090137655 Non-Steroidal Ligands for the Glucocorticoid Receptor, Compositions and Uses Thereof
05/28/2009US20090137585 N-acylsulfonamide apoptosis promoters
05/28/2009US20090137567 Methods for Treating Blood Disorders
05/28/2009US20090137393 2,4,6-trialkylphenyl substituted cyclopentane-1,3-dione
05/28/2009CA2703893A1 Compound
05/27/2009EP2061449A1 Substituted acetylenic compounds useful for the treatment of diseases
1 ... 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 ... 183